WHO briefing on malaria treatment guidelines and artemisinin monotherapies
In January 2006, on the occasion of the release of the first edition of the Guidelines for the treatment of malaria, WHO issued a press release urging 17 known companies to stop marketing artemisinin monotherapies, and to re-direct their production efforts towards artemisinin-based combination therapies. The press release received major attention in the international media and in the national press in endemic countries. Before the press release was issued, all concerned companies were invited to a technical briefing in Washington, but only two were able to attend.
In order to share more information with 41 companies active in this sector, a second meeting was scheduled in Geneva in April 2006. Twenty-six pharmaceutical companies involved in production and marketing of artemisinin monotherapies for oral treatment of uncomplicated falciparum malaria attended the WHO Briefing on malaria treatment guidelines and artemisinin monotherapies, held on 19 April 2006 in Executive Board Room, WHO Geneva.